{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:10:12Z","timestamp":1791382212524,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"am","delay-in-days":333,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.otc.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T01:05:13Z","timestamp":1682730313000},"page":"421-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Updates on Tumor Biology in Vestibular Schwannoma"],"prefix":"10.1016","volume":"56","author":[{"given":"Aida","family":"Nourbakhsh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine T.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.otc.2023.02.004_bib1","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1097\/MAO.0000000000002613","article-title":"Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2","volume":"41","author":"Dinh","year":"2020","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.otc.2023.02.004_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","volume":"35","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/3.2.347","article-title":"Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma","volume":"3","author":"Irving","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"12","key":"10.1016\/j.otc.2023.02.004_bib4","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1073\/pnas.1102198108","article-title":"Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function","volume":"108","author":"Yang","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s004390050188","article-title":"Mutational spectrum in the neurofibromatosis type 2 gene in sporadic and familial schwannomas","volume":"98","author":"Welling","year":"1996","journal-title":"Hum Genet"},{"issue":"10","key":"10.1016\/j.otc.2023.02.004_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jmedgenet-2017-104519","article-title":"Genetic Severity Score predicts clinical phenotype in NF2","volume":"54","author":"Halliday","year":"2017","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib7","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.devcel.2012.03.008","article-title":"The tumor suppressor merlin controls growth in its open state, and phosphorylation converts it to a less-active more-closed state","volume":"22","author":"Sher","year":"2012","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.otc.2023.02.004_bib8","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3892\/ijo.2013.1798","article-title":"Microarray analysis of gene expression in vestibular schwannomas reveals SPP1\/MET signaling pathway and androgen receptor deregulation","volume":"42","author":"Torres-Martin","year":"2013","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4161\/15384047.2014.972765","article-title":"Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells","volume":"16","author":"Dilwali","year":"2015","journal-title":"Cancer Biol Ther"},{"issue":"8","key":"10.1016\/j.otc.2023.02.004_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/neuonc\/noq012","article-title":"ErbB\/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma","volume":"12","author":"Ammoun","year":"2010","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/MAO.0b013e31823e287f","article-title":"Treatment of vestibular schwannoma cells with ErbB inhibitors","volume":"33","author":"Bush","year":"2012","journal-title":"Otol Neurotol"},{"issue":"19","key":"10.1016\/j.otc.2023.02.004_bib12","doi-asserted-by":"crossref","first-page":"31666","DOI":"10.18632\/oncotarget.15912","article-title":"Ponatinib promotes a G1 cell-cycle arrest of merlin\/NF2-deficient human schwann cells","volume":"8","author":"Petrilli","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00129492-200501000-00017","article-title":"VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate","volume":"26","author":"Caye-Thomasen","year":"2005","journal-title":"Otol Neurotol"},{"issue":"11","key":"10.1016\/j.otc.2023.02.004_bib14","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1158\/1535-7163.MCT-17-0417","article-title":"Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells","volume":"16","author":"Fuse","year":"2017","journal-title":"Mol Cancer Therapeut"},{"issue":"34","key":"10.1016\/j.otc.2023.02.004_bib15","doi-asserted-by":"crossref","first-page":"54515","DOI":"10.18632\/oncotarget.10248","article-title":"Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1","volume":"7","author":"Troutman","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.otc.2023.02.004_bib16","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1080\/01616412.2017.1376494","article-title":"Reduced RAC1 activity inhibits cell proliferation and induces apoptosis in neurofibromatosis type 2(NF2)-associated schwannoma","volume":"39","author":"Wang","year":"2017","journal-title":"Neurol Res"},{"issue":"42","key":"10.1016\/j.otc.2023.02.004_bib17","doi-asserted-by":"crossref","first-page":"30643","DOI":"10.1074\/jbc.M702573200","article-title":"CD44 regulates hepatocyte growth factor-mediated vascular integrity. Role of c-Met, Tiam1\/Rac1, dynamin 2, and cortactin","volume":"282","author":"Singleton","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2009.04.019","article-title":"PAK kinase regulates Rac GTPase and is a potential target in human schwannomas","volume":"218","author":"Flaiz","year":"2009","journal-title":"Exp Neurol"},{"issue":"8","key":"10.1016\/j.otc.2023.02.004_bib19","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/MAO.0b013e31814b2787","article-title":"Expression of vascular endothelial growth factor and basic fibroblast growth factor in sporadic vestibular schwannomas correlates to growth characteristics","volume":"28","author":"Koutsimpelas","year":"2007","journal-title":"Otol Neurotol"},{"issue":"3","key":"10.1016\/j.otc.2023.02.004_bib20","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.3892\/mmr.2015.3932","article-title":"Tanshinone IIA exerts antitumor activity against vestibular schwannoma cells by inhibiting the expression of hypoxia-inducible factor-1alpha","volume":"12","author":"Kim","year":"2015","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1593\/neo.111600","article-title":"Merlin\/NF2 regulates angiogenesis in schwannomas through a Rac1\/semaphorin 3F-dependent mechanism","volume":"14","author":"Wong","year":"2012","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lary.22392","article-title":"Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas","volume":"122","author":"Jacob","year":"2012","journal-title":"Laryngoscope"},{"issue":"12","key":"10.1016\/j.otc.2023.02.004_bib23","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-15-1144","article-title":"YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis","volume":"76","author":"Guerrant","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.otc.2023.02.004_bib24","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.wneu.2018.06.010","article-title":"Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma","volume":"117","author":"Zhao","year":"2018","journal-title":"World Neurosurg"},{"issue":"7","key":"10.1016\/j.otc.2023.02.004_bib25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.molonc.2015.03.009","article-title":"Preclinical validation of anti-nuclear factor-kappa B therapy to inhibit human vestibular schwannoma growth","volume":"9","author":"Dilwali","year":"2015","journal-title":"Mol Oncol"},{"key":"10.1016\/j.otc.2023.02.004_bib26","doi-asserted-by":"crossref","first-page":"984529","DOI":"10.3389\/fnmol.2022.984529","article-title":"Single-cell sequencing reveals the cell map and transcriptional network of sporadic vestibular schwannoma","volume":"15","author":"Yidian","year":"2022","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-018-2788-6","article-title":"Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors","volume":"138","author":"Wang","year":"2018","journal-title":"J\u00a0Neuro Oncol"},{"key":"10.1016\/j.otc.2023.02.004_bib28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3389\/fimmu.2019.01084","article-title":"Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages","volume":"10","author":"Orecchioni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.otc.2023.02.004_bib29","first-page":"1","article-title":"Predominance of M1 subtype among tumor-associated macrophages in phenotypically aggressive sporadic vestibular schwannoma","author":"Perry","year":"2019","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MAO.0b013e31827c9fbf","article-title":"Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas","volume":"34","author":"de Vries","year":"2013","journal-title":"Otol Neurotol"},{"issue":"3","key":"10.1016\/j.otc.2023.02.004_bib31","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00428-018-2503-1","article-title":"M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma","volume":"474","author":"de Vries","year":"2019","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/2473974X211059111","article-title":"Tumor-Associated Macrophages in Vestibular Schwannoma and Relationship to Hearing","volume":"5","author":"Nisenbaum","year":"2021","journal-title":"OTO Open"},{"issue":"11","key":"10.1016\/j.otc.2023.02.004_bib33","doi-asserted-by":"crossref","first-page":"9940","DOI":"10.18632\/oncotarget.24119","article-title":"CXCR4: A new player in vestibular schwannoma pathogenesis","volume":"9","author":"Breun","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3892\/mmr.2015.3415","article-title":"Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue","volume":"12","author":"Taurone","year":"2015","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.otc.2023.02.004_bib35","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/glia.20651","article-title":"Overexpression of CXCL16 and its receptor CXCR6\/Bonzo promotes growth of human schwannomas","volume":"56","author":"Held-Feindt","year":"2008","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1440-1789.2003.00541.x","article-title":"Expression of macrophage inflammatory protein-1alpha in Schwann cell tumors","volume":"24","author":"Mori","year":"2004","journal-title":"Neuropathology"},{"issue":"13","key":"10.1016\/j.otc.2023.02.004_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage Polarization States in the Tumor Microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MAO.0b013e31828048ec","article-title":"Sporadic vestibular schwannomas associated with good hearing secrete higher levels of fibroblast growth factor 2 than those associated with poor hearing irrespective of tumor size","volume":"34","author":"Dilwali","year":"2013","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.otc.2023.02.004_bib39","doi-asserted-by":"crossref","first-page":"18599","DOI":"10.1038\/srep18599","article-title":"Secreted Factors from Human Vestibular Schwannomas Can Cause Cochlear Damage","volume":"5","author":"Dilwali","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2014.12.007","article-title":"Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas","volume":"166","author":"Dilwali","year":"2015","journal-title":"Transl Res"},{"key":"10.1016\/j.otc.2023.02.004_bib41","doi-asserted-by":"crossref","first-page":"107770","DOI":"10.1016\/j.heares.2019.07.007","article-title":"NLRP3 inflammasome activation in human vestibular schwannoma: Implications for tumor-induced hearing loss","volume":"381","author":"Sagers","year":"2019","journal-title":"Hear Res"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib42","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41598-017-04100-1","article-title":"Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"10.1016\/j.otc.2023.02.004_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1023\/A:1026575610124","article-title":"The contributions of cyclooxygenase-2 to tumor angiogenesis","volume":"19","author":"Gately","year":"2000","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.otc.2023.02.004_bib44","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/978-1-59745-396-7_16","article-title":"Analysis of matrix metalloproteinase secretion by macrophages","volume":"531","author":"Elkington","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1016\/j.otc.2023.02.004_bib45","first-page":"866","article-title":"Cystic vestibular schwannomas: a possible role of matrix metalloproteinase-2 in cyst development and unfavorable surgical outcome","volume":"106","author":"Moon","year":"2007","journal-title":"J\u00a0Neurosurg"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib46","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/lary.20834","article-title":"Angiogenesis in vestibular schwannomas: expression of extracellular matrix factors MMP-2, MMP-9, and TIMP-1","volume":"120","author":"Moller","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2023.02.004_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fncel.2020.00191","article-title":"MMP-14 (MT1-MMP) Is a Biomarker of Surgical Outcome and a Potential Mediator of Hearing Loss in Patients With Vestibular Schwannomas","volume":"14","author":"Ren","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.otc.2023.02.004_bib48","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1016\/j.wneu.2020.07.208","article-title":"Immunohistochemical Profiles of Matrix Metalloproteinases and Vascular Endothelial Growth Factor Overexpression in the Antoni B Area of Vestibular Schwannomas","volume":"144","author":"Xia","year":"2020","journal-title":"World Neurosurg"},{"issue":"7","key":"10.1016\/j.otc.2023.02.004_bib49","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1097\/MAO.0000000000000788","article-title":"Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics","volume":"36","author":"de Vries","year":"2015","journal-title":"Otol Neurotol"},{"issue":"3","key":"10.1016\/j.otc.2023.02.004_bib50","first-page":"911","article-title":"Genetic landscape of sporadic vestibular schwannoma","volume":"128","author":"Havik","year":"2018","journal-title":"J\u00a0Neurosurg"},{"issue":"11","key":"10.1016\/j.otc.2023.02.004_bib51","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/ng.3688","article-title":"The genomic landscape of schwannoma","volume":"48","author":"Agnihotri","year":"2016","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.otc.2023.02.004_bib52","doi-asserted-by":"crossref","first-page":"e65868","DOI":"10.1371\/journal.pone.0065868","article-title":"Global profiling in vestibular schwannomas shows critical deregulation of microRNAs and upregulation in those included in chromosomal region 14q32","volume":"8","author":"Torres-Martin","year":"2013","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.otc.2023.02.004_bib53","doi-asserted-by":"crossref","first-page":"12618","DOI":"10.1074\/jbc.M512615200","article-title":"The ubiquitin isopeptidase UBPY regulates endosomal ubiquitin dynamics and is essential for receptor down-regulation","volume":"281","author":"Row","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib55","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1212\/WNL.0000000000001129","article-title":"Mutations in LZTR1 add to the complex heterogeneity of schwannomatosis","volume":"84","author":"Smith","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1158\/2159-8290.CD-12-0361","article-title":"ARID1A mutations in cancer: another epigenetic tumor suppressor?","volume":"3","author":"Wu","year":"2013","journal-title":"Cancer Discov"},{"issue":"15","key":"10.1016\/j.otc.2023.02.004_bib57","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.otc.2023.02.004_bib58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","article-title":"Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma","volume":"6","author":"Kino","year":"2001","journal-title":"Gene Cell"},{"issue":"15","key":"10.1016\/j.otc.2023.02.004_bib59","first-page":"5601","article-title":"CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas","volume":"9","author":"Gonzalez-Gomez","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.otc.2023.02.004_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1365-2990.2010.01090.x","article-title":"CpG island hypermethylation of the neurofibromatosis type 2 (NF2) gene is rare in sporadic vestibular schwannomas","volume":"36","author":"Kullar","year":"2010","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"8","key":"10.1016\/j.otc.2023.02.004_bib61","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/01.mao.0000226291.42165.22","article-title":"DNA methylation of multiple genes in vestibular schwannoma: Relationship with clinical and radiological findings","volume":"27","author":"Lassaletta","year":"2006","journal-title":"Otol Neurotol"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib62","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/gcc.22232","article-title":"Genome-wide methylation analysis in vestibular schwannomas shows putative mechanisms of gene expression modulation and global hypomethylation at the HOX gene cluster","volume":"54","author":"Torres-Martin","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.otc.2023.02.004_bib63","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/MAO.0b013e3181f20655","article-title":"MicroRNA-21 overexpression contributes to vestibular schwannoma cell proliferation and survival","volume":"31","author":"Cioffi","year":"2010","journal-title":"Otol Neurotol"},{"issue":"5","key":"10.1016\/j.otc.2023.02.004_bib64","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00701-020-04238-4","article-title":"Tumor miRNA expression profile is related to vestibular schwannoma growth rate","volume":"162","author":"Sass","year":"2020","journal-title":"Acta Neurochir"},{"key":"10.1016\/j.otc.2023.02.004_bib65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.abb.2014.07.012","article-title":"MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma","volume":"563","author":"Poenitzsch Strong","year":"2014","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.otc.2023.02.004_bib66","doi-asserted-by":"crossref","first-page":"110986","DOI":"10.1016\/j.biopha.2020.110986","article-title":"Regulatory role of microRNAs on PTEN signaling","volume":"133","author":"Ghafouri-Fard","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib67","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MAO.0b013e3181be6478","article-title":"Deregulated genes in sporadic vestibular schwannomas","volume":"31","author":"Caye-Thomasen","year":"2010","journal-title":"Otol Neurotol"},{"issue":"1","key":"10.1016\/j.otc.2023.02.004_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/mao.0b013e31816021f7","article-title":"Phosphatidylinositol 3-kinase\/AKT pathway activation in human vestibular schwannoma","volume":"29","author":"Jacob","year":"2008","journal-title":"Otol Neurotol"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.jnen.0000199575.93794.2f","article-title":"Neuregulin growth factors and their ErbB receptors form a potential signaling network for schwannoma tumorigenesis","volume":"65","author":"Stonecypher","year":"2006","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"4","key":"10.1016\/j.otc.2023.02.004_bib70","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1227\/NEU.0b013e3181ec7b71","article-title":"Global gene expression profiling and tissue microarray reveal novel candidate genes and down-regulation of the tumor suppressor gene CAV1 in sporadic vestibular schwannomas","volume":"67","author":"Aarhus","year":"2010","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.otc.2023.02.004_bib71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-016-2292-9","article-title":"Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas","volume":"131","author":"Sass","year":"2017","journal-title":"J\u00a0Neuro Oncol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523000269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666523000269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:07:16Z","timestamp":1683086836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666523000269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S0030666523000269"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2023.02.004","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on Tumor Biology in Vestibular Schwannoma","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}